BIA Separations Expanding its Distribution Network in India
News May 30, 2015
BIA Separations has announced the expansion of its distribution network in India through collaboration with Medi Analytika India Pvt. Ltd.
The collaboration will leverage BIA Separations' leading position in the development and manufacture of monolith chromatography, and Medi Analytika's position as one of the leading instrumentation companies in India.
As of 15th May, BIA Separations' analytical and preparative CIM monolith columns, including CIMac™, CIM® and CIMmultus™ will also be available to the Indian customers through Medi Analytika as well as services which will be performed by a joint group of experts of both companies.
Medi Analytika India Pvt. Ltd. is one of the leading instrumentation companies in India and has a separate team of engineers for every product division to address the demands of their customers to utmost satisfaction. Their engineers have adequate experience and exposure to various laboratory, medical and industrial equipments.
They install and provide after-sales-service support for a wide range of instruments and equipments. They have supplied various sophisticated instruments to almost all researchers throughout India into various Industries, Research centers, Universities and Hospitals. Medi Analytika has offices at Chennai (Head office), Hyderabad (South India), Calcutta (East India), Mumbai (West India) and Delhi (North India).
Innovative Chromatography Technologies to be Discussed at Preconference WorkshopNews
Biopharmaceutical researchers from around the globe will discuss innovative chromatographic approaches and technologies for purifying diverse biomolecules during a preconference workshop sponsored by Bio-Rad Laboratories, Inc.READ MORE
First Ever Online Event Focused on Cannabis ScienceNews
Analytical Cannabis is pleased to announce that the final line-up of speakers for the first ever cannabis science online event, The Science of Cannabis 2017 has been confirmed.READ MORE
Study Findings Could Lead to a Better Cholesterol TreatmentNews
New research from Aarhus University has now uncovered the way in which PCSK9 breaks down the LDL receptors, which are a kind of receptor molecule that absorbs the bad LDL cholesterol in the blood into the liver.READ MORE